Center for Biologics Evaluation and Research (U.S.). (2004). Guidance for industry: Use of nucleic acid tests on pooled and individual samples from donors of whole blood and plasma components (including source plasma and source leukocytes) to adequately and appropriately reduce the risk of transmission of HIV-1 and HCV. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research.
Chicago Style (17th ed.) CitationCenter for Biologics Evaluation and Research (U.S.). Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Plasma Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately Reduce the Risk of Transmission of HIV-1 and HCV. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2004.
MLA (9th ed.) CitationCenter for Biologics Evaluation and Research (U.S.). Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Plasma Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately Reduce the Risk of Transmission of HIV-1 and HCV. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2004.